Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab | MicrobiomeTrials← Back to trialsNCT06710223
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-01-03Est. Completion: 2027-12
Enrollment target: 16 participants Locations- University of California, San Diego, San Diego, California, United States
Other microbiome trials you might be interested in
Hepatocellular Carcinoma
A single institution, single arm, two-cohort feasibility trial to evaluate the combination of locoregional Y\^90 therapy…
New York, United StatesEst. completion Aug 1, 2027
Chronic HepatitisHepatitis C InfectionHepatocellular Carcinoma
This phase I trial studies the side effects and best dose of deoxyribonucleic acid (DNA) vaccine therapy in treating pat…
Jacksonville, United StatesEst. completion Mar 4, 2020